Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19
Jean M. Connors(Harvard University), Juvenal Martinez(Association Clinique et Thérapeutique Infantile du Val de Marne), Victoria Altagracia(Association Clinique et Thérapeutique Infantile du Val de Marne), Joseph Bledsoe, Maria M. Brooks, Deborah Martin(University of Pittsburgh), Bridget‐Anne Kirwan, Fred Blind(Association Clinique et Thérapeutique Infantile du Val de Marne), Lauren Castro(University of Illinois Chicago), Donald Schreiber, Elaine Zaharris(Brigham and Women's Hospital), Brendan M. Everett(Cedars-Sinai Medical Center), Nancy L. Shapiro(University of Illinois Chicago), Heather Eng(University of Pittsburgh), Sarah Majercik(Intermountain Medical Center), Daniel O. Haight(Regional Health), Lisa H. Merck(University of Florida), Dominick J. Angiolillo(University of Florida), Frank C. Sciurba(Pulmonary and Allergy Associates), Kabir Yadav(Association Clinique et Thérapeutique Infantile du Val de Marne), Anthony G. Vecchiarelli(University of Michigan), Janet Lin(University of Illinois Chicago), Zhuxuan Fu(Saint Luke's Health System), Jerry A. Krishnan(Chicago Department of Public Health), Carl J. Pepine(Cedars-Sinai Medical Center), Renato D. Lópes(Duke University), John H. Alexander(Ohio State University Hospital), Scott R. Beach(Harvard University), Jason Wilson(University of South Florida), Godson Oguchi(University of Florida), Eileen Handberg(University of Florida), Eric Leifer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Andrei Kindzelski(National Institutes of Health), Peter C. Hou(Brigham and Women's Hospital), Rob Mentz(Association Clinique et Thérapeutique Infantile du Val de Marne), Michelle Sholzberg(St. Michael's Hospital), Aldo P. Maggioni(Health Care Foundation), Scott C. Brakenridge(University of Florida), Reinaldo Loy(Association Clinique et Thérapeutique Infantile du Val de Marne), Paul M. Ridker(Herlev Hospital), Vidya Venugopal(Centre for Chronic Disease Control), Yongqi Zhong(Gilead Sciences (United States)), Amanda L. Baucom(University of Pittsburgh), Steve Wisniewski(University of Pittsburgh), Eddie Armas, John J. Cienki(Association Clinique et Thérapeutique Infantile du Val de Marne), Jeff Jacobson(Association Clinique et Thérapeutique Infantile du Val de Marne), Andrea B. Troxel(Andover Eye Associates)
Cited by 265
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k